| 1 | [000000000] | - | - | - | - | [1] 66 66 💬
|
| 2 | [ALXN1210] | - | - | - | - | [6] 2 2, 11, 13, 50, 62, 66 💬
|
| 3 | [Atrasentan] | [1] Atrasentan Atrasentan | [1] Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 4 | [BCX9930] | - | - | - | - | [4] 62 62, 66, 222, 223 💬
|
| 5 | [Dapagliflozin] | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 66 66 💬
|
| 6 | [LNP023] | - | - | - | - | [2] 62 62, 66 💬
|
| 7 | [Metilprednisolone sodio succinato] | - | - | - | - | [2] 14 14, 66 💬
|
| 8 | [Nefecon] | - | - | - | - | [1] 66 66 💬
|
| 9 | [OMS721] | - | - | - | - | [1] 66 66 💬
|
| 10 | [Prednisone] | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 19 19, 66, 90, 300, 303 💬
|
| 11 | [RE-021] | - | - | - | - | [3] 66 66, 218, 222 💬
|
| 12 | A-623 or AMG 623 | - | - | - | - | [1] 66 66 💬
|
| 13 | A07EA06 | - | - | - | - | [1] 66 66 💬
|
| 14 | Abelmoschus manihot | - | - | - | - | [1] 66 66 💬
|
| 15 | ACE inhibitor | - | - | - | - | [1] 66 66 💬
|
| 16 | ACE inhibitor + statin | - | - | - | - | [2] 66 66, 223 💬
|
| 17 | ACE Inhibitor or Angiotensin receptor antagonist | - | - | - | - | [1] 66 66 💬
|
| 18 | ACE/ARB | - | - | - | - | [1] 66 66 💬
|
| 19 | ACEi | - | - | - | - | [2] 66 66, 224 💬
|
| 20 | ACEI/ARB and corticosteroids | - | - | - | - | [1] 66 66 💬
|
| 21 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 22 | Acteoside | [1] Acteoside Acteoside | - | - | - | [1] 66 66 💬
|
| 23 | ACTH (Acthar) Gel | - | - | - | - | [1] 66 66 💬
|
| 24 | Acthar 80 unit injection | - | - | - | - | [1] 66 66 💬
|
| 25 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | - | - | - | - | [2] 62 62, 66 💬
|
| 26 | ADX-038 Dose Level 1 | - | - | - | - | [2] 66 66, 223 💬
|
| 27 | ADX-038 Dose Level 2 | - | - | - | - | [2] 66 66, 223 💬
|
| 28 | ADX-097 | - | - | - | - | [1] 66 66 💬
|
| 29 | Aliskiren | [1] Aliskiren Aliskiren | [2] Aliskiren
Aliskiren
,
Aliskiren fumarate
💬
| [1] REN REN 💬
| [3] Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [4] 66 66, 167, 222, 223 💬
|
| 30 | Allopurinol | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [7] 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 31 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 💬
|
| 32 | ALXN1210 | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 33 | ALXN2050 | - | - | - | - | [3] 11 11, 62, 66 💬
|
| 34 | Ambrisentan | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 51 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
|
| 35 | Angiotensin blockade | - | - | - | - | [1] 66 66 💬
|
| 36 | Angiotensin II | [1] Angiotensin II Angiotensin II | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| [2] AGTR1 AGTR1, AGTR2 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 37 | Anti-CD19/BCMA CAR NK cells | - | - | - | - | [1] 66 66 💬
|
| 38 | Anti-CD19/BCMA CAR NK cells (KN5601) | - | - | - | - | [2] 66 66, 222 💬
|
| 39 | APL-2 | - | - | - | - | [6] 2 2, 61, 62, 66, 222, 223 💬
|
| 40 | ARB | - | - | - | - | [1] 66 66 💬
|
| 41 | ARO-C3 | - | - | - | - | [2] 66 66, 223 💬
|
| 42 | ARO-CFB | - | - | - | - | [1] 66 66 💬
|
| 43 | Artesunate | [1] Artesunate Artesunate | [1] Artesunate
Artesunate
💬
| - | - | [4] 18 18, 66, 86, 96 💬
|
| 44 | AT-1501 | - | - | - | - | [1] 66 66 💬
|
| 45 | Atacicept | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [5] 13 13, 46, 49, 66, 222 💬
|
| 46 | Atacicept 150 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 47 | Atacicept 25 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 13 13, 66 💬
|
| 48 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 49 | ATG-F | - | - | - | - | [2] 66 66, 223 💬
|
| 50 | ATRASENTAN | [1] Atrasentan Atrasentan | [1] Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 66 66, 218, 222 💬
|
| 51 | Avacopan | [1] Avacopan Avacopan | [1] Avacopan
Avacopan
💬
| [1] C5AR1 C5AR1 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | [4] 43 43, 44, 66, 223 💬
|
| 52 | AVB-S6-500 | - | - | - | - | [1] 66 66 💬
|
| 53 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 54 | Azilsartan | [1] Azilsartan Azilsartan | [1] Azilsartan
Azilsartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 55 | Bardoxolone | [1] Bardoxolone Bardoxolone | [1] Bardoxolone
Bardoxolone
💬
| - | - | [7] 66 66, 67, 84, 85, 86, 218, 222 💬
|
| 56 | Bardoxolone methyl | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | [7] 66 66, 67, 84, 85, 86, 218, 222 💬
|
| 57 | Bardoxolone methyl capsules | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | [4] 66 66, 67, 86, 222 💬
|
| 58 | BCX9930 | - | - | - | - | [4] 62 62, 66, 222, 223 💬
|
| 59 | BCX9930 hydrochloride | - | - | - | - | [4] 62 62, 66, 222, 223 💬
|
| 60 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [17] 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 61 | Benlysta | - | - | - | - | [7] 43 43, 48, 49, 53, 63, 66, 222 💬
|
| 62 | BENLYSTA® (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 63, 66, 222 💬
|
| 63 | BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO | - | - | - | - | [3] 62 62, 66, 223 💬
|
| 64 | BHV-1400 | - | - | - | - | [1] 66 66 💬
|
| 65 | Bio-Kult Advanced | - | - | - | - | [1] 66 66 💬
|
| 66 | BION-1301 | - | - | - | - | [1] 66 66 💬
|
| 67 | BION-1301 Multiple Doses | - | - | - | - | [1] 66 66 💬
|
| 68 | BION-1301 Single Dose | - | - | - | - | [1] 66 66 💬
|
| 69 | Blisibimod | [1] Blisibimod Blisibimod | [1] Blisibimod
Blisibimod
💬
| - | - | [5] 43 43, 44, 49, 63, 66 💬
|
| 70 | Blisibimod Injection | [1] Blisibimod Blisibimod | [1] Blisibimod
Blisibimod
💬
| - | - | [1] 66 66 💬
|
| 71 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 72 | BNJ441 | - | - | - | - | [1] 66 66 💬
|
| 73 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 74 | Bortezomib (Velcade®) | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 66 66 💬
|
| 75 | BUDESONIDE | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 66 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
|
| 76 | C09 | - | - | - | - | [1] 66 66 💬
|
| 77 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [11] 18 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
|
| 78 | CCX168 | - | - | - | - | [6] 43 43, 44, 49, 66, 109, 223 💬
|
| 79 | CD19 CAR-?d T cell | - | - | - | - | [2] 66 66, 222 💬
|
| 80 | CD19-targeted iNKT Cell Injection | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 81 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [6] 11 11, 15, 62, 66, 109, 223 💬
|
| 82 | Chinese Herb Prescription Granule plus prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 83 | Cilazapril | [1] Cilazapril Cilazapril | [2] Cilazapril
Cilazapril
,
Cilazapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 66 66 💬
|
| 84 | CM313 | - | - | - | - | [1] 66 66 💬
|
| 85 | CM338 | - | - | - | - | [1] 66 66 💬
|
| 86 | Corticosteroid | - | - | - | - | [12] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
|
| 87 | Corticotherapy | - | - | - | - | [1] 66 66 💬
|
| 88 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [9] 2 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
|
| 89 | Cyclophosphamid | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 66 66, 223 💬
|
| 90 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 91 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 92 | Decortin H | - | - | - | - | [2] 66 66, 145 💬
|
| 93 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 46 46, 49, 51, 66, 96, 222, 224 💬
|
| 94 | Drug: Atrasentan | [1] Atrasentan Atrasentan | [1] Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 95 | Enalapril | [1] Enalapril Enalapril | [2] Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [10] 13 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬
|
| 96 | ENALAPRIL VALSARTAN METHYLPREDNISONE | [3] Enalapril Enalapril, Methylprednisone, Valsartan | [3] Valsartan
Valsartan
,
Enalapril maleate
,
Enalapril
💬
| [2] ACE ACE, AGTR1 💬
| [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 97 | EVER001 | - | - | - | - | [2] 66 66, 222 💬
|
| 98 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [14] 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 99 | Fecal microbiota transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [9] 2 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
|
| 100 | Felzartamab | [1] Felzartamab Felzartamab | - | - | - | [2] 66 66, 222 💬
|
| 101 | Finerenone | [1] Finerenone Finerenone | [1] Finerenone
Finerenone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [5] 66 66, 218, 222, 223, 224 💬
|
| 102 | Fish Oil | [1] Fish oil Fish oil | - | - | - | [10] 13 13, 46, 49, 50, 66, 79, 96, 260, 294, 299 💬
|
| 103 | FOS | - | - | - | - | [2] 66 66, 96 💬
|
| 104 | Fostamatinib | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 61, 63, 66 💬
|
| 105 | Fostamatinib 100 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 106 | Fostamatinib 100 mg tablet | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 107 | Fostamatinib 150 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 108 | Fostamatinib 150 mg tablet | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 109 | Fostamatinib Disodium | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 61, 63, 66 💬
|
| 110 | Fostamatinib Disodium tablet 100 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 111 | Fostamatinib Disodium tablet 150 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 💬
|
| 112 | Galactose | [1] Galactose Galactose | [1] Galactose
Galactose
💬
| - | - | [4] 66 66, 171, 222, 257 💬
|
| 113 | Gastrus | - | - | - | - | [1] 66 66 💬
|
| 114 | Genetic: PS-002 | - | - | - | - | [1] 66 66 💬
|
| 115 | GlucoCorticoid | - | - | - | - | [7] 46 46, 49, 66, 113, 223, 228, 300 💬
|
| 116 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 117 | GSK1550188 | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 118 | Gut-directed budesonide and SoC | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 119 | HAEMOPHILUS INFLUENZAE | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 120 | Henagliflozin | [1] Henagliflozin Henagliflozin | - | - | - | [3] 58 58, 66, 218 💬
|
| 121 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 122 | High Dose-VIS649 | - | - | - | - | [1] 66 66 💬
|
| 123 | Hormone (prednisone) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 124 | HR19042 capsule | - | - | - | - | [1] 66 66 💬
|
| 125 | HR19042 Capsule, Tarpeyo®, Budenofalk® | - | - | - | - | [2] 66 66, 95 💬
|
| 126 | HR19042 Capsules | - | - | - | - | [2] 66 66, 95 💬
|
| 127 | HRS-5965 | - | - | - | - | [2] 66 66, 223 💬
|
| 128 | HRS-5965 Capsules | - | - | - | - | [2] 62 62, 66 💬
|
| 129 | HRS-5965 tablets | - | - | - | - | [2] 62 62, 66 💬
|
| 130 | HS-10390 | - | - | - | - | [1] 66 66 💬
|
| 131 | HS-10390 tablet | - | - | - | - | [2] 66 66, 222 💬
|
| 132 | HS-10542 High Dose | - | - | - | - | [1] 66 66 💬
|
| 133 | HS-10542 Low Dose | - | - | - | - | [1] 66 66 💬
|
| 134 | HSK39297 | - | - | - | - | [2] 62 62, 66 💬
|
| 135 | HSK39297 100mgBID | - | - | - | - | [1] 66 66 💬
|
| 136 | HSK39297 200mgQD | - | - | - | - | [1] 66 66 💬
|
| 137 | HSK39297 300mgQD | - | - | - | - | [1] 66 66 💬
|
| 138 | HSK39297 50mgBID | - | - | - | - | [1] 66 66 💬
|
| 139 | Human soluble recombinant Fc-gamma receptor IIB | - | - | - | - | [1] 66 66 💬
|
| 140 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 141 | Hydroxychloroquine and SoC | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [2] 66 66, 223 💬
|
| 142 | Hydroxychloroquine Oral Tablet | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [2] 63 63, 66 💬
|
| 143 | Hydroxychloroquine sulfate | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [5] 13 13, 46, 48, 53, 66 💬
|
| 144 | Immune Suppressant | - | - | - | - | [1] 66 66 💬
|
| 145 | Immunosuppressants | - | - | - | - | [1] 66 66 💬
|
| 146 | Immunosuppressive treatment | - | - | - | - | [1] 66 66 💬
|
| 147 | Infusion of ADR-001 (Mesenchymal stem cell) | - | - | - | - | [2] 66 66, 223 💬
|
| 148 | Inhibace/Cozaar | - | - | - | - | [2] 66 66, 223 💬
|
| 149 | Intervention for incipient patients at low risk of disease progression | - | - | - | - | [1] 66 66 💬
|
| 150 | Intervention for patients at high risk of disease progression | - | - | - | - | [1] 66 66 💬
|
| 151 | Intravenous Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 66 66 💬
|
| 152 | IONIS-FB-LRx | - | - | - | - | [1] 66 66 💬
|
| 153 | Iptacopan | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 154 | Iptacopan hydrochloride | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [5] 61 61, 63, 66, 109, 223 💬
|
| 155 | Irbesartan | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [6] 57 57, 66, 167, 168, 222, 223 💬
|
| 156 | Irbesartan tablets | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 157 | Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03 | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 158 | JADE101 | - | - | - | - | [1] 66 66 💬
|
| 159 | KP104 | - | - | - | - | [4] 49 49, 62, 66, 223 💬
|
| 160 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [14] 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
|
| 161 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] Prednisone
Prednisone
,
Leflunomide
💬
| [2] DHODH DHODH, NR3C1 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [2] 66 66, 223 💬
|
| 162 | Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [9] 19 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
|
| 163 | LNP023 | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|
| 164 | LNP023 HYDROCHLORI | - | - | - | - | [1] 66 66 💬
|
| 165 | Losartan | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [20] 17 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
|
| 166 | Low antigen content diet | - | - | - | - | [1] 66 66 💬
|
| 167 | Low Dose-VIS649 | - | - | - | - | [1] 66 66 💬
|
| 168 | MASP-2 Antibody, OMS00620646, OMS620646 | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [1] 66 66 💬
|
| 169 | Medium Dose-VIS649 | - | - | - | - | [1] 66 66 💬
|
| 170 | Menatetrenone | [1] Menatetrenone Menatetrenone | [1] Menatetrenone
Menatetrenone
💬
| - | - | [2] 66 66, 97 💬
|
| 171 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | - | - | - | - | [3] 62 62, 66, 223 💬
|
| 172 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [31] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 173 | Methylprednisolon | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 51 51, 66, 223 💬
|
| 174 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 175 | Methylprednisolone (drug) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 66 💬
|
| 176 | Methylprednisolone (MP) or prednisone (pred) | [2] Methylprednisolone Methylprednisolone, Prednisone | [3] Methylprednisolone
Methylprednisolone
,
Prednisone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 177 | METHYLPREDNISOLONE MYLAN Générique | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 178 | Methylprednisolone pulse | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 179 | Methylprednisolone succinate | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 66 💬
|
| 180 | Methylprednisolone(intravenously in the 1st-2nd-3rd month ) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 181 | Methylprednisolone(intravenously in the 1st-3rd-5th month) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 182 | Methylprednisone | [1] Methylprednisone Methylprednisone | - | - | - | [4] 46 46, 66, 85, 222 💬
|
| 183 | Metilprednisolone sodio succinato | - | - | - | - | [4] 13 13, 14, 56, 66 💬
|
| 184 | Mezagitamab | [1] Mezagitamab Mezagitamab | [1] Mezagitamab
Mezagitamab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 63 63, 66, 223 💬
|
| 185 | MIL116 | - | - | - | - | [1] 66 66 💬
|
| 186 | Mizoribine | [1] Mizoribine Mizoribine | [1] Mizoribine
Mizoribine
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 💬
|
| 187 | MOR03087 | - | - | - | - | [2] 66 66, 222 💬
|
| 188 | MOR202 | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 189 | Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH) | - | - | - | - | [1] 66 66 💬
|
| 190 | MY008211A tablets | - | - | - | - | [2] 62 62, 66 💬
|
| 191 | Mycophenolat-Natrium | - | - | - | - | [1] 66 66 💬
|
| 192 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 193 | Mycophenolate mofetil (MMF) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 13 13, 49, 51, 60, 65, 66, 222, 223 💬
|
| 194 | Mycophenolate mofetil (MMF) and SoC | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 66 66, 223 💬
|
| 195 | Mycophenolate mofetil plus lower dose of Prednisone | [2] Mycophenolate mofetil Mycophenolate mofetil, Prednisone | [3] Prednisone
Prednisone
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 66 66 💬
|
| 196 | Mycophenolate sodium | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [6] 49 49, 53, 66, 222, 223, 228 💬
|
| 197 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [9] 11 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
|
| 198 | Mycophenolic sodium | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 199 | Myfortic | - | - | - | - | [5] 49 49, 66, 222, 223, 228 💬
|
| 200 | Myfortic 180mg Tablets | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 201 | Myfortic 360mg Tablets | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 202 | Narsoplimab | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [3] 66 66, 222, 223 💬
|
| 203 | NEFECON | - | - | - | - | [2] 66 66, 223 💬
|
| 204 | Nefecon 16mg daily | - | - | - | - | [1] 66 66 💬
|
| 205 | Nefecon®,Ambrisentan | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 206 | NM8074 | - | - | - | - | [5] 50 50, 62, 66, 109, 223 💬
|
| 207 | Non-steroidal mineralocorticoid receptor antagonist and SoC | - | - | - | - | [2] 66 66, 223 💬
|
| 208 | NTQ5082 capsules 100 mg | - | - | - | - | [1] 66 66 💬
|
| 209 | NTQ5082 capsules 200 mg | - | - | - | - | [2] 62 62, 66 💬
|
| 210 | NTQ5082 capsules 300 mg | - | - | - | - | [1] 66 66 💬
|
| 211 | Omega-3 fatty acid ethylester90 | - | - | - | - | [1] 66 66 💬
|
| 212 | Omega-3 Fatty Acid Fish Oil Supplement | [1] Fish oil Fish oil | - | - | - | [1] 66 66 💬
|
| 213 | OMS721 | - | - | - | - | [3] 64 64, 66, 109 💬
|
| 214 | OMS721 (narsoplimab) | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [3] 66 66, 222, 223 💬
|
| 215 | OPL-CCL2-LPM | - | - | - | - | [1] 66 66 💬
|
| 216 | Oral prednisolone and SoC | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 217 | Other: Blood collection | - | - | - | - | [7] 15 15, 28, 36, 49, 66, 67, 223 💬
|
| 218 | Other: Blood test | - | - | - | - | [11] 10 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
|
| 219 | Other: continue their usual therapy | - | - | - | - | [1] 66 66 💬
|
| 220 | Other: intensive supportive care | - | - | - | - | [1] 66 66 💬
|
| 221 | Other: Optimized Supportive Care | - | - | - | - | [1] 66 66 💬
|
| 222 | Other: urine sample | - | - | - | - | [7] 46 46, 49, 66, 177, 223, 240, 335 💬
|
| 223 | Other: Vehicle (D5W or saline) | - | - | - | - | [1] 66 66 💬
|
| 224 | Over-encapsulated 150 mg Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 225 | Over-encapsulated Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 💬
|
| 226 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] Paricalcitol
Paricalcitol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 19 19, 66, 218, 238, 298 💬
|
| 227 | Plasma exchange (PE) | - | - | - | - | [6] 11 11, 13, 64, 66, 221, 223 💬
|
| 228 | PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml | - | - | - | - | [2] 62 62, 66 💬
|
| 229 | Potassium | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [17] 36 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
|
| 230 | Povetacicept | [1] Povetacicept Povetacicept | [1] Povetacicept
Povetacicept
💬
| [1] TNFRSF13B TNFRSF13B 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | [5] 11 11, 61, 63, 66, 222 💬
|
| 231 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 232 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 233 | Prednisolone plus Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisolone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisolone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 234 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 235 | Prednisone + Inhibace/Cozaar | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 236 | Prednisone 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 66 💬
|
| 237 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 35 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
|
| 238 | Prednisone alone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 66 💬
|
| 239 | Prednisone and cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 240 | PREDNISONE ARROW 20mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 241 | PREDNISONE ARROW 5 mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 242 | Prednisone in full dose | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 243 | Prednisone or Prednisolone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 84 💬
|
| 244 | Prednisone plus cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 245 | Probiotics combined with enteric-coated budesonide capsule | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 223 💬
|
| 246 | Probucol | [1] Probucol Probucol | [1] Probucol
Probucol
💬
| - | - | [4] 21 21, 66, 79, 223 💬
|
| 247 | Proline | [1] Proline Proline | [1] Proline
Proline
💬
| - | - | [3] 66 66, 94, 97 💬
|
| 248 | ProTectis | - | - | - | - | [1] 66 66 💬
|
| 249 | QT-219CX | - | - | - | - | [3] 51 51, 66, 222 💬
|
| 250 | R935788 | - | - | - | - | [4] 46 46, 61, 63, 66 💬
|
| 251 | Ramipril | [1] Ramipril Ramipril | [1] Ramipril
Ramipril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [10] 46 46, 49, 57, 66, 67, 113, 218, 222, 223, 257 💬
|
| 252 | Rapamune | - | - | - | - | [8] 2 2, 60, 66, 67, 84, 158, 278, 280 💬
|
| 253 | RAS 2410 | - | - | - | - | [1] 66 66 💬
|
| 254 | RAS inhibitor | - | - | - | - | [1] 66 66 💬
|
| 255 | RAVULIZUMAB | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 2 2, 11, 13, 50, 62, 66, 109, 224 💬
|
| 256 | RC18 160mg | - | - | - | - | [3] 11 11, 13, 66 💬
|
| 257 | RC18 240mg | - | - | - | - | [2] 13 13, 66 💬
|
| 258 | RE-021 | - | - | - | - | [3] 66 66, 218, 222 💬
|
| 259 | Reh-acteoside | [1] Acteoside Acteoside | - | - | - | [1] 66 66 💬
|
| 260 | Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i) | - | - | - | - | [1] 66 66 💬
|
| 261 | RG002C0106 | - | - | - | - | [1] 66 66 💬
|
| 262 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 263 | SC0062 high dose | - | - | - | - | [1] 66 66 💬
|
| 264 | SC0062 low dose | - | - | - | - | [1] 66 66 💬
|
| 265 | SC0062 medium dose | - | - | - | - | [1] 66 66 💬
|
| 266 | SC0062 strength 10mg | - | - | - | - | [1] 66 66 💬
|
| 267 | SCTC21C | - | - | - | - | [1] 66 66 💬
|
| 268 | Sefaxersen (RO7434656) | - | - | - | - | [1] 66 66 💬
|
| 269 | SGB-9768 | - | - | - | - | [2] 66 66, 223 💬
|
| 270 | Shenqi Yishen Granules | - | - | - | - | [1] 66 66 💬
|
| 271 | SHR-2010 Injection | - | - | - | - | [1] 66 66 💬
|
| 272 | SHR-2173 injection | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 273 | Sibeprenlimab | [1] Sibeprenlimab Sibeprenlimab | [1] Sibeprenlimab
Sibeprenlimab
💬
| [1] TNFSF13 TNFSF13 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬 | [1] 66 66 💬
|
| 274 | Simulect | - | - | - | - | [3] 66 66, 97, 223 💬
|
| 275 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [22] 6 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
|
| 276 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 277 | Sirolimus (study drug)+ACE inhibitor + statin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 66 66, 223 💬
|
| 278 | SLN12140 | - | - | - | - | [2] 62 62, 66 💬
|
| 279 | SM101 | - | - | - | - | [3] 49 49, 63, 66 💬
|
| 280 | SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML | - | - | - | - | [1] 66 66 💬
|
| 281 | SoC defined as maximal labelled or tolerated dose of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker (ACEi/ARB) & steady dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i) | - | - | - | - | [2] 66 66, 223 💬
|
| 282 | SOLU MEDROL | - | - | - | - | [2] 56 56, 66 💬
|
| 283 | SOLU MEDROL - 1000 MG/16 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 1000 MG+ 1 FLACONE SOLVENTE DA 16 ML | - | - | - | - | [1] 66 66 💬
|
| 284 | SPARSENTAN | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 66 66, 218, 222, 223 💬
|
| 285 | Sparsentan compresse | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 286 | Sparsentan tablets/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 287 | Sparsentan tablets/over-encapsulated Spasenten tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 288 | Sparsentan tablets/Overencapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 289 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 290 | Steroids plus azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 66 66 💬
|
| 291 | Supportive and immunosuppressive therapy | - | - | - | - | [1] 66 66 💬
|
| 292 | Supportive therapy | - | - | - | - | [2] 66 66, 223 💬
|
| 293 | Supportive therapy with: ACE-inhibitor / ARB / Statin | - | - | - | - | [1] 66 66 💬
|
| 294 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 295 | Tailored diet | - | - | - | - | [1] 66 66 💬
|
| 296 | TARPEYO 4 MG Delayed Release Oral Capsule | - | - | - | - | [1] 66 66 💬
|
| 297 | TARPEYO® | - | - | - | - | [1] 66 66 💬
|
| 298 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 299 | Telitacicept 160mg | [1] Telitacicept Telitacicept | - | - | - | [3] 49 49, 66, 223 💬
|
| 300 | Telitacicept 240mg | [1] Telitacicept Telitacicept | - | - | - | [1] 66 66 💬
|
| 301 | Telmisartan | [1] Telmisartan Telmisartan | [1] Telmisartan
Telmisartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [5] 6 6, 57, 66, 67, 222 💬
|
| 302 | Tetracycline | [1] Tetracycline Tetracycline | [2] Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | [5] 13 13, 46, 53, 66, 97 💬
|
| 303 | The Yi-Qi-Qing-Jie herbal compound | - | - | - | - | [1] 66 66 💬
|
| 304 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 305 | Tonsillectomy | - | - | - | - | [1] 66 66 💬
|
| 306 | Tripterygium wilfordii (TW) | - | - | - | - | [2] 66 66, 222 💬
|
| 307 | UCAR T-cell | - | - | - | - | [7] 11 11, 13, 14, 49, 51, 66, 222 💬
|
| 308 | Ultomiris | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 309 | Ultomiris 300 mg/30 ml | - | - | - | - | [1] 66 66 💬
|
| 310 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 311 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 312 | VACCINO PNEUMOCOCCICO | - | - | - | - | [2] 62 62, 66 💬
|
| 313 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 314 | Valsartan | [1] Valsartan Valsartan | [1] Valsartan
Valsartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [11] 28 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬
|
| 315 | VIS649 | - | - | - | - | [1] 66 66 💬
|
| 316 | VT-001 | - | - | - | - | [1] 66 66 💬
|
| 317 | Warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [15] 6 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
|
| 318 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 319 | WM (Shentong Granules) | - | - | - | - | [1] 66 66 💬
|
| 320 | XH-S003 Capsule | - | - | - | - | [2] 62 62, 66 💬
|
| 321 | YKST02 | - | - | - | - | [2] 49 49, 66 💬
|
| 322 | Zigakibart | [1] Zigakibart Zigakibart | [1] Zigakibart
Zigakibart
💬
| [1] TNFSF13 TNFSF13 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬 | [2] 66 66, 223 💬
|
| 323 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|